Ahmed, F.W.; Bakhashab, S.; Bastaman, I.T.; Crossland, R.E.; Glanville, M.; Weaver, J.U.
Anti-Angiogenic miR-222, miR-195, and miR-21a Plasma Levels in T1DM Are Improved by Metformin Therapy, Thus Elucidating Its Cardioprotective Effect: The MERIT Study. Int. J. Mol. Sci. 2018, 19, 3242.
https://doi.org/10.3390/ijms19103242
AMA Style
Ahmed FW, Bakhashab S, Bastaman IT, Crossland RE, Glanville M, Weaver JU.
Anti-Angiogenic miR-222, miR-195, and miR-21a Plasma Levels in T1DM Are Improved by Metformin Therapy, Thus Elucidating Its Cardioprotective Effect: The MERIT Study. International Journal of Molecular Sciences. 2018; 19(10):3242.
https://doi.org/10.3390/ijms19103242
Chicago/Turabian Style
Ahmed, Fahad W., Sherin Bakhashab, Inda T. Bastaman, Rachel E. Crossland, Michael Glanville, and Jolanta U. Weaver.
2018. "Anti-Angiogenic miR-222, miR-195, and miR-21a Plasma Levels in T1DM Are Improved by Metformin Therapy, Thus Elucidating Its Cardioprotective Effect: The MERIT Study" International Journal of Molecular Sciences 19, no. 10: 3242.
https://doi.org/10.3390/ijms19103242
APA Style
Ahmed, F. W., Bakhashab, S., Bastaman, I. T., Crossland, R. E., Glanville, M., & Weaver, J. U.
(2018). Anti-Angiogenic miR-222, miR-195, and miR-21a Plasma Levels in T1DM Are Improved by Metformin Therapy, Thus Elucidating Its Cardioprotective Effect: The MERIT Study. International Journal of Molecular Sciences, 19(10), 3242.
https://doi.org/10.3390/ijms19103242